continu lofti expect
updat forecast estim may
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research may
estim may
price data jun
rate updat jun
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
stori one constant chang firm
found manufactur compon wwii aircraft
final divest industri busi full
transit medic devic thereaft leadership
former ceo benson smith compani complet transit
industri conglomer pure-play medic devic
manufactur core busi focus vascular surgeri
anesthesia end market
firm strategi effect carv nich market
compet thu far remain rel insul
intens competit largest player med-tech
manag target market opportun
compani suppli dispos product
mandatori
procedur creat rel stabl demand associ
cash flow addit product portfolio primarili contain
low dollar valu item along increment innov
allow compani improv margin profil modest
price inflat time combin like-for-lik price
power smith character direct market access core
tenant compani strategi led slowli
acquir foreign distribut partner provid better line
sight end market allow firm captur otherwis
lost distributor margin lead sustain predict gross
smith retir end anticip strategi
like remain unchang new ceo former liam
kelli recent acquisit vascular solut neotract
help improv firm margin profil believ high
price paid limit contribut near term
addit grow goodwil compon firm invest
capit base held histor return weight averag
cost capit wed like see evid compani
trend toward sustain econom profit gener
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
wayn pennsylvania-bas manufactur hospit suppli
medic devic primarili within vascular access surgic area
firm report eight primari segment vascular north america
sale intervent north america anesthesia north
asia origin equip manufactur
geograph exposur busi primarili
account revenu intern market make
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
slightli rais fair valu estim firm
per share account cash flow
receiv sinc last updat valuat impli
roughli time time estim
adjust earn ebitda respect
updat outlook project busi continu
solid perform anticip firm grow
revenu near compound-annual-growth-rate forecast period
outlook newli acquir vascular solut
neotract busi drive expect acceler
growth addit add nearli
respect growth core revenu base
addit improv gross margin mix
addit busi inform expect
nearli basi point gross margin gain
baselin forecast consist manag
goal adjust oper margin trend toward
time mix play critic role good portion
project margin expans firm profit
core also pois improv on-going
given uncertainti creat integr sizabl
acquisit complet cours last year
rate uncertainti high bull case
incorpor busi fundament valuat
believ would like associ take-out-lik
level forecast core revenu acceler
period enhanc growth profil
vascular solut neotract result compound-annual-growth-rate
forecast period addit assum
manag oper margin target
exceed result valu per share
approxim time time time bull-cas
forecast adjust earn ebitda sale
bear-cas forecast contempl scenario
sizabl impair goodwil would like occur
case forecast slow core revenu growth less
stellar contribut recent acquisit
result revenu compound-annual-growth-rate approxim
addit estim restructur effort fail
meaning expand core gross margin
oper expens level fail meet exist synergi
target still expect oper margin expand
case forecast fall well short manag
target result valuat per share
nearer time time time lower estim
adjust earn ebitda sale respect
yet clear us abl dig
moat firm develop lead posit hand
market acquisit dont yet
confid meaning outperform
estim wacc decad believ
conting
manag abil sourc valu integr futur
acquisit constitut basi
moat histor profil support
stanc -- prior acquisit yet materi
enhanc firm return given substanti goodwil
alloc recur cost relat integr
restructur effort suggest deal valuat
expens side wed like see
evid valu creation adjust current view
howev think manag strategi target
product low absolut price point effect
hospit continu becom
sensit firm product portfolio somewhat uniqu
item carri sticker price less
believ help insul busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
medic suppli industri gener view
switch cost intang asset cost advantag
like sourc underpin competit moat
focus enhanc product portfolio
acquisit isnt support moat
isol view dont see evid
moat sourc present product portfolio
center around low-cost single-us product reli
physician prefer group purchas organ
gpo contract repeat sale deepli
either procur
administr end user addit firm margin
profil on-going manufactur consolid
restructur effort suggest us uniqu cost
advantag current exist -- although anticip
margin improv come year manag
optim compani cost structur
addit hesit award moat base
underinvest research develop
compar peer sinc transit pure play
medic busi compani spent
revenu averag research develop effort
versu peer bard
spent nearer high-single-digit percentag
revenu basi multipl
abl spend absolut dollar us impli
 compon strategi outsiz
impact rel competitor believ
put firm disadvantag environ
attract acquisit hard come
appear manag appetit acquisit
acceler cours close two deal
billion total valu think
deal includ interest asset dont believ
combin inher enhanc valu
combin compani competit posit expect
industrywid price pressur thu far actual
allow compani rais price modestli time
howev believ manag act
price opportun avail compani assum
price benefit go forward mix relat rather
like-for-lik price power view firm vascular
surgic anesthesia franchis area like
develop futur moat firm respiratori
oem busi rather commodit
overal focus acquir product
top three four competitor make gener
two third total market vascular access
cathet laryng mask laparoscop surgeri
gener compet hand firm
mani case lead product arrow
line central cathet lma laryng mask portfolio
competit posit current favor
clear firm develop sourc
advantag give us confid abil defend
better capit competitor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
pressur view addit either
recent deal fail meet expect believ
materi risk capit base given current make-up
compani balanc sheet case
intang asset goodwil make nearli total
asset valu versu peer closer averag
pursu similar strategi monitor
progress deal chang firm-wide
care evid posit neg inflect
assess compani underli moat trend
final concern focus
product market limit barrier entri
product littl way intang
regul framework minim switch
cost outsid inertia part hospit procur
administr favor gpo relationship combin
underinvest intern worri
defens firm current market posit
given size scope primari competitor
addit vascular solut neotract
improv firm growth margin profil
concern valuat paid limit accret
near term dont anticip impli return
sharehold deal exceed estim
firm cost capit three four year
doesnt jump us obvious value-add proposit
addit neotract repres one riski
opportun taken given billion
all-in price single-product firm year
view underli moat trend stabl
compani enjoy modest share gain year
undergon acquisit enhanc
firm posit tangenti market believ
product ad uniqu opportun
product portfolio dont view inclus
asset sustain improv weaken
underli competit posit
busi
addit valuat paid look expens
side rather obviou bargain calcul
manag commentari
accret combin near term us
limit return improv suggest underli
moat sourc unlik improv inclus
acquisit alon
believ potenti upsid exist base-cas
assumpt regard acquisit particularli
case neotract given larg unmet need within
benign prostat hyperplasia bph market want
remain cogniz bigger pictur believ teleflex
need continu sourc acquisit backfil
research develop pipelin increas
uncertainti regard develop platform abil
busi respond effect competit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
gross margin profil meaning
improv higher margin vascular solut
neotract begin out-grow core franchis
clinic benefit area unmet need market
opportun substanti could repres home-
run acquisit sale continu grow current
owhil firm financi model continu
perform ahead expect perform
recent acquisit critic meet free
ohistor acquisit yet materi
compani profil given
substanti goodwil alloc -- verdict still
manag capit alloc prowess
product portfolio competit strategi
resembl bard could make
viabl take-out candid given bard acquisit
goodwil intang asset much
larger portion balanc sheet compar
peer pursu similar strategi could indic
over-pay histor deal
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
think financi posit solid follow
substanti balanc sheet de-lever wake
acquisit firm complet
moder ahead histor rang well support
firm growth prospect believ compani
strong cash flow profil along continu growth
oper leverag put leverag
time end result
surpris see announc transact
end year estim firm approxim
million tax-affect pension oblig nearli
million balanc sheet leas financ modestli
worsen compani overal indebted profil
combin littl less billion gross debt
estim total obligation/adjust ebitda
ratio sit near time howev believ compani
adequ access liquid form
million annual free cash flow along million
current avail revolv line credit
risk associ
assign high uncertainti rate due
profil near term would highlight potenti
value-destruct post-leadership transit
rel unconcern possibl given kelli
tenur addit expect integr
vascular solut neotract produc
wacc return capit within year high price
paid creat meaning risk capit base expect
growth fail materi addit highlight
risk stem firm limit invest
realiz return intern activ view
compani intern develop engin somewhat
lack would highlight materi underinvest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
 vs peer spent roughli sale
 averag last five year versu bard
north becton dickinson near
better averag fill gap
acquisit anticip continu
find value-add candid critic firm
success go forward addit believ signific
portion compani product portfolio limit
protect custom switch cost enhanc
risk firm current market posit view
market environ provid acquisit
candid new manag team fail effect
sourc opportun think risk put
structur competit disadvantag time
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
capit research manag compani
share
fund
share
fund
award manag team standard mark
stewardship due success firm
leadership benson smith tenur ceo sinc
smith serv board member sinc
elev ceo role mark end histori
industri conglomer signal board
support firm strateg evolut pure-play
devic experi c-suit spent
nearli year career bard includ
late believ manag effect
alloc sharehold capit year
acquisit divestitur activ build
medic portfolio also like nich product
strategi compani pursu larg
insul busi price pressur seen broadli
across industri last year
howev smith retir ceo role end
preclud us award team exemplari
rate although new ceo liam kelli part
compani execut team sinc held titl
sinc wed like get better sens
strateg vision capit alloc strategi firm
overal view manag compens reason
believ interest manag team
align minor sharehold insid
ownership encourag corpor director
offic own outstand share includ
underli option rsu smith own
annual
compens structur includ roughli equiti
base pay meaning vest period view
posit annual option grant vest ratabl
three-year period annual rsu vest entireti
three-year period perform metric base
compani addit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
primarili annual revenu ep target combin
weight tie oper cash flow
remain individu target think
consist mani compani cover wed
prefer heavier emphasi cash flow return capit
opinion better measur corpor
perform adjust incom statement item
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
first-quart result put teleflex track
first-quart result consist
expect underli basi report number
fell slightli short due stronger currenc headwind
anticip nevertheless appear firm well
way meet forecast full year
like rais per share fair valu estim
no-moat name mid-single-digit percentag account
cash flow receiv sinc last updat
firm post constant currenc revenu growth
ahead initi guidanc call full
year strength broad base across geographi
product segment new product firm
intervent portfolio continu outpac core
busi neotract particular continu impress
revenu growth quarter pace beat
estim full year restructur charg
also came ahead model due quick ramp-up
cost associ manag footprint
year good start surpris
see return sizabl dealmak later
year net leverag declin roughli time
adjust ebitda anticip metric fall
nearer time end balanc sheet
look much improv follow success neotract
vascular solut integr leav manag
billion dri powder avail without
go much high end histor
time net leverag coven surpris
see debt level rise level sustain period
full-year result initi outlook
no-moat report result fell line
expect provid initi outlook
larg bracket estim like rais
per share fair valu estim mid-single-digit
percentag account cash flow receiv sinc
last updat dont intend make mani meaning
chang assumpt
notabl firm report full-year organ constant-
currenc revenu growth near low end
manag forecast previous
anticip includ out-performance
neotract vascular solut versu fourth-quart
remain mute explain modest neg market
reaction news forward guidanc look reason
good manag anticip constant-
currenc revenu growth although compani face
headwind currenc cours
year versu benefit seen earn
fell line project includ modest
increment spend associ get firm
urolift product reimburs japan follow earlier-
than-expect approv expand sale support
product global invest limit firm abil
drive oper leverag come year
contend underli perform continu trend
line manag long-term outlook
final firm announc anoth restructur plan
help support gross margin outlook
enterpris time compani adept
improv cost good year even
control benefit attribut acquir higher-
margin line busi last year
firm leverag ratio set fall time
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
surpris see manag pursu
anoth larger transact medium term
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
